Memantine prevents aluminum-induced cognitive deficit in rats.
Behav Brain Res
; 225(1): 31-8, 2011 Nov 20.
Article
em En
| MEDLINE
| ID: mdl-21741993
ABSTRACT
Memantine, a noncompetitive NMDA receptor blocker, has been demonstrated to be neuroprotective against various neurotoxins. Aluminum, a well-known neurotoxin, has been suggested to be a contributing factor in Alzheimer's disease. In this study we investigated the possible effect of memantine on aluminum-induced cognitive impairment in rats. Rats were exposed to aluminum chloride (100mg/kg/day) and memantine (5, 10 and 20mg/kg/day) for 60 days. Cognitive functions were evaluated using three tests Morris water maze, radial arm maze and passive avoidance tests. Results showed that memantine failed at low doses to have any significant influence on aluminum-induced memory deficit, but the 20mg/kg dose was found to cause significant enhancement of memory in the aluminum-exposed rats. This is the first study to demonstrate the protective role of memantine against aluminum-induced neuronal dysfunction. Biochemical and histological investigations are highly indicated to clarify the possible pharmacodynamic basis.
Texto completo:
1
Coleções:
01-internacional
Temas:
Agentes_cancerigenos
Base de dados:
MEDLINE
Assunto principal:
Memantina
/
Transtornos Cognitivos
/
Antagonistas de Aminoácidos Excitatórios
/
Alumínio
Tipo de estudo:
Prognostic_studies
Limite:
Animals
Idioma:
En
Revista:
Behav Brain Res
Ano de publicação:
2011
Tipo de documento:
Article